Nazareth Earns ACR Lung Cancer Screening Accreditation
Philadelphia, PA (June 19, 2017): Nazareth Hospital has earned accreditation from the American College of Radiology (ACR) for its Lung Cancer Screening Center. ACR accreditation recognizes lung cancer screening facilities that have committed to practice safe and effective diagnostic care for patients at the highest risk for lung cancer. Nazareth Hospital is committed to providing its patients with the best methods possible of early detection.
“This accreditation marks yet another success in Nazareth Hospital’s continuing commitment to safe and effective care,” said Donald S. Ostrum, MD, Chair of Radiology. “Our high quality imaging and screening program helps us better serve our community by allowing us to diagnose and treat lung cancers sooner.”
This year, more than 220,000 Americans will discover they have lung cancer. According to the American Lung Association, nearly 160,000 Americans die each year from lung cancer. This accounts for more fatalities than breast, colon and prostate cancers combined. Lung cancer screening with low-dose computed tomography scans, and appropriate follow-up care, significantly reduces lung cancer deaths.
To receive an ACR designation, facilities must be accredited by the ACR in computed tomography in the chest module, as well as undergo a rigorous assessment of its lung cancer screening protocol and infrastructure. Facilities must also maintain diligent practices for follow-up patient care, such as counseling and smoking cessation programs.
For more information about medical imaging at Nazareth Hospital, call 1.866.NAZARETH (1.866.629.2738).